Filtraglass
Banner
Falorni Tech Glass Melting Technology

SCHOTT launches production of amber pharma glass in India

To meet the increasing demand in Asia, SCHOTT invested EUR 75 million (approximatively INR 660) over the last three years to expand its pharmaceutical glass production in India.

The Gujarat-based facility is the company’s manufacturing hub for borosilicate glass tubing, a high-quality material that is converted to pharmaceutical containers, such as vials, ampoules or syringes, to store life-saving drugs. This expansion contributes to the Indian government’s vision of further strengthening India as a global pharmaceutical hub, while also supporting Germany’s commitment to increasingly invest in India – as recently agreed upon by Chancellor Olaf Scholz and Indian Prime Minister Narendra Modi.

At the official opening event today, local government officials, business unit executives, and pharma industry representatives celebrated the start of a new production of FIOLAX® amber pharmaceutical glass tubing. With this move, manufacturers of drug containment solutions in in the region can now receive SCHOTT’s complete portfolio of pharmaceutical glass tubing produced in India. Amber glass is used to store light-sensitive medications such as antibiotics or chemotherapeutic agents. The local production will also improve availability, planning reliability, and cost efficiency for pharmaceutical converters.

Sign up for free to the glassOnline.com daily newsletter

Subscribe now to our daily newsletter for full coverage of everything you need to know about the world glass industry!

We don't send spam! Read our Privacy Policy for more information.

Share this article
Related news